Activins and inhibins in endocrine and other tumors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Endocrine reviews

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/EDRV.22.6.0450PMID 11739336
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line

  2005cited by this paper
• すい臓癌におけるACVR1B(ALK4、1B型アクチビン受容体)遺伝子の突然変異

  2001cited by this paper
• Inhibin and p27 interact to regulate gonadal tumorigenesis.

  2001cited by this paper
• The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.

  2001cited by this paper
• ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma

  2001cited by this paper
• Chromosomal changes during development and progression of prostate adenocarcinomas

  2001cited by this paper
• Pituitary tumorigenesis and hPit-1 cells.

  2001cited by this paper
• The contribution of inhibins and activins to malignant prostate disease.

  2001cited by this paper
• Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

  2001cited by this paper
• Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH

  2000cited by this paper
• Activin βC and βE Genes Are Not Essential for Mouse Liver Growth, Differentiation, and Regeneration

  2000cited by this paper
• Assessment of inhibin and p53 in granulosa cell tumors of the ovary.

  2000influential reference
• A genome screen of multiplex sibships with prostate cancer.

  2000cited by this paper
• Signaling of transforming growth factor‐β family members through Smad proteins

  2000cited by this paper
• Ageing, testicular tumours and the pituitary-testis axis in dogs.

  2000cited by this paper
• Activin effects on neoplastic proliferation of human pituitary tumors.

  2000cited by this paper
• Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.

  2000cited by this paper
• Genetic changes in breast cancer detected by comparative genomic hybridisation

  2000cited by this paper
• The Smad pathway.

  2000cited by this paper
• Genetic progression and divergence in pancreatic carcinoma.

  2000cited by this paper
• Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family.

  2000cited by this paper
• Signaling inputs converge on nuclear effectors in TGF-beta signaling.

  2000cited by this paper
• Signaling inputs converge on nuclear effectors in TGF-β signaling

  2000cited by this paper
• Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH)

  2000cited by this paper
• Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening.

  2000cited by this paper
• Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

  2000cited by this paper
• Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis

  2000cited by this paper
• Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer.

  2000cited by this paper
• Allelotype of pancreatic acinar cell carcinoma

  2000cited by this paper
• Identification and Characterization of a Novel Follistatin-like Protein as a Binding Protein for the TGF-β Family*

  2000cited by this paper
• Regulation of inhibin production in the human male and its clinical applications.

  2000cited by this paper
• Evidence for microsatellite instability in bilateral breast carcinomas.

  2000cited by this paper
• Characterization of an immortalized human granulosa cell line (COV434).

  2000cited by this paper
• Activin signal transduction pathways.

  2000cited by this paper
• Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.

  2000cited by this paper
• Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception.

  2000cited by this paper
• In search of binding--identification of inhibin receptors.

  2000cited by this paper
• Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.

  2000cited by this paper
• Is the action of inhibin mediated via a unique receptor?

  2000cited by this paper
• Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.

  2000cited by this paper
• Assignment1 of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2→q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH

  2000cited by this paper
• N-myc down-regulates activin A.

  2000cited by this paper
• Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.

  2000cited by this paper
• Patterns of chromosomal imbalances in invasive breast cancer

  2000cited by this paper
• Genetic abnormalities in mammary ductal intraepithelial neoplasia‐flat type (“clinging ductal carcinoma in situ”)

  2000cited by this paper
• Long-term testosterone treatment prevents gonadal and adrenal tumorigenesis of mice transgenic for the mouse inhibin-alpha subunit promoter/simian virus 40 T-antigen fusion gene.

  2000cited by this paper
• Signaling of transforming growth factor-beta family members through Smad proteins.

  2000cited by this paper
• Structure and expression of a membrane component of the inhibin receptor system.

  2000cited by this paper
• Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma

  2000cited by this paper
• Editorial: In Search of Binding-Identification of Inhibin Receptors.

  2000cited by this paper
• The roles of inhibin and related peptides in gonadal function.

  2000cited by this paper
• Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal tumors.

  2000cited by this paper
• Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors.

  2000cited by this paper
• Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors?

  2000influential reference
• Smads as transcriptional co-modulators.

  2000cited by this paper
• Identification of Genetic Markers for Prostatic Cancer Progression

  2000influential reference
• The expression of inhibin/activin subunits in the human adrenal cortex and its tumours.

  1999cited by this paper
• Undetectable inhibin B serum levels in men after testicular irradiation.

  1999cited by this paper
• Genetic alterations in ERBB2-amplified breast carcinomas.

  1999cited by this paper
• Anti‐α‐inhibin

  1999cited by this paper
• Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.

  1999cited by this paper
• Adult granulosa cell tumor of the ovary with foci of hepatic cell differentiation: a report of four cases and comparison with two cases of granulosa cell tumor with Leydig cells.

  1999cited by this paper
• Specificity, diversity, and regulation in TGF‐β superfamily signaling

  1999cited by this paper
• Inhibin subunit gene expression in ovarian cancer.

  1999cited by this paper
• Secretion of activin A in recurrent epithelial ovarian carcinoma.

  1999cited by this paper
• Genetic pattern of prostate cancer progression

  1999cited by this paper
• Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer

  1999cited by this paper
• Inhibin is not an immunohistochemical marker for hepatocellular carcinoma. An example of the potential pitfall in diagnostic immunohistochemistry caused by endogenous biotin.

  1999cited by this paper
• Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.

  1999cited by this paper
• Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation.

  1999cited by this paper
• Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.

  1999cited by this paper
• Inhibin forms in serum from postmenopausal women with ovarian cancers

  1999cited by this paper
• Placental site nodule and characterization of distinctive types of intermediate trophoblast.

  1999cited by this paper
• Mutational Analysis of Activin / Transforming Growth Factor-b Type I and Type II Receptor Kinases in Human Pituitary Tumors *

  1999cited by this paper
• Widespread chromosomal abnormalities in high‐grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high‐grade DCIS

  1999cited by this paper
• Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.

  1999cited by this paper
• Immunohistochemical Localization of Inhibin-α in the Placenta and Gestational Trophoblastic Lesions

  1999cited by this paper
• Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1‐associated pancreatic endocrine tumors

  1999cited by this paper
• Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis.

  1999cited by this paper
• Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.

  1999cited by this paper
• Combined inhibin and CA125 assays in the detection of ovarian cancer.

  1999influential reference
• Detection of the alpha-subunit of inhibin in trophoblastic neoplasia.

  1999cited by this paper
• Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2.

  1999cited by this paper
• Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.

  1999cited by this paper
• Granulosa cell tumour of the testis displaying immunoreactivity for inhibin

  1999cited by this paper
• Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.

  1999cited by this paper
• Expression of activin A and follistatin core proteins by human prostate tumor cell lines.

  1999cited by this paper
• Molecular abnormalities associated with secretory carcinomas of the breast.

  1999cited by this paper
• Specificity, diversity, and regulation in TGF-beta superfamily signaling.

  1999cited by this paper
• Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors

  1999cited by this paper
• Immunohistochemical localization of alpha- and betaA-subunits of inhibin/activin in human normal endocrine cells and related tumors of the digestive system.

  1999cited by this paper
• Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer

  1999cited by this paper
• Immunohistochemical localization of α- and βA-subunits of inhibin/activin in human normal endocrine cells and related tumors of the digestive system

  1999cited by this paper
• Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors.

  1999cited by this paper
• Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues

  1999influential reference
• Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors.

  1999cited by this paper
• Identification of high affinity binding sites for inhibin on ovine pituitary cells in culture.

  1999cited by this paper
• Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid.

  1999cited by this paper
• Comparative allelotyping of the short arm of human chromosome 3 in epithelial tumors of four different types.

  1999cited by this paper
• Roles of pathway-specific and inhibitory Smads in activin receptor signaling.

  1999cited by this paper

• MSC1 Cells Suppress Colorectal Cancer Cell Growth via Metabolic Reprogramming, Laminin–Integrin Adhesion Signaling, Oxidative Stress Resistance, and a Tumor-Suppressive Secretome

  2025cites this paper
• Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy

  2024cites this paper
• Downregulated INHBB in endometrial tissue of recurrent implantation failure patients impeded decidualization through the ADCY1/cAMP signalling pathway

  2023cites this paper
• Identification and verification of anoikis-related gene markers to predict the prognosis of patients with bladder cancer and assist in the diagnosis and treatment of bladder cancer

  2023cites this paper
• A83-01 and DMH1 effects in the zebrafish spermatogonial niche: unraveling the roles of TGF-β and BMP signaling in the Fsh-mediated spermatogonial fate.

  2023cites this paper
• Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways

  2022cites this paper
• TGF-β and BMP subfamily pathways in zebrafish spermatogonial niche: A83-01 and DMH1 inhibitor effects in spermatogonial self-renewal and differentiation

  2022cites this paper
• Clinical relevance of circulating activin A and follistatin in small cell lung cancer.

  2021cites this paper
• A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer

  2020cites this paper
• INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer

  2020cites this paper
• Wound Repair, Scar Formation, and Cancer: Converging on Activin.

  2020cites this paper
• Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia.

  2020cites this paper
• Activin B Promotes Hepatic Fibrogenesis

  2019cites this paper
• Increased activin A levels in prediabetes and association with carotid intima-media thickness: a cross-sectional analysis from I-Lan Longitudinal Aging Study

  2018cites this paper
• Inhibin B suppresses anoikis resistance and migration through the transforming growth factor‐β signaling pathway in nasopharyngeal carcinoma

  2018cites this paper
• Association between serum activin A and metabolic syndrome in older adults: Potential of activin A as a biomarker of cardiometabolic disease

  2018cites this paper
• Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast.

  2018cites this paper
• The effects of activin A on the migration of human breast cancer cells and neutrophils and their migratory interaction

  2017cites this paper
• Inhibin-α gene mutations and mRNA levels in human lymphoid and myeloid leukemia cells.

  2017cites this paper
• Smad3/4 Binding to Promoter II of P450arom So As to Regulate Aromatase Expression in Endometriosis

  2017cites this paper
• Over-Expression of Activin-βC Is Associated with Murine and Human Prostate Disease.

  2017cites this paper
• Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B–Secreting Adrenocortical Carcinoma

  2017cites this paper
• Expression of Activin During and After Chemotherapy in Peripheral Blood of Patients with Primary Breast Cancer.

  2016cites this paper
• Development of A Testicular Cancer Vaccine

  2016cites this paper
• Uric acid: a modulator of prostate cells and activin sensitivity

  2016cites this paper
• Chromatin Remodeling as the New Target for Breast Cancer Prevention

  2016cites this paper
• Apoptosis modulation by activin A and follistatin in human endometrial stromal cells

  2016cites this paper
• Neuropeptides and Control of the Anterior Pituitary

  2016cites this paper
• SMAD3 Activation: A Converging Point of Dysregulated TGF-Beta Superfamily Signaling and Genetic Aberrations in Granulosa Cell Tumor Development?

  2016cites this paper
• Activins and Inhibins: Roles in Development, Physiology, and Disease.

  2016cites this paper
• The role of Activin B and TGFb1 in regulating endometrial cancer cell adhesion and migration

  2016influential citation
• Cell-Cell Communication Networks Propose a Modulation of the Hematopoietic Stem Cell Niche by Invading Breast Carcinoma Cells

  2015cites this paper
• Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling

  2015cites this paper
• The Uric Acid Story: Linking the Big Toe to the Prostate

  2014cites this paper
• FOXL2-induced follistatin attenuates activin A-stimulated cell proliferation in human granulosa cell tumors.

  2014cites this paper
• The inhibin/activin signalling pathway in human gonadal and adrenal cancers.

  2014cites this paper
• A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events

  2014cites this paper
• Recent Developments in β-Cell Differentiation of Pluripotent Stem Cells Induced by Small and Large Molecules

  2014cites this paper
• Pattern of Serum Inhibin B Hormone Secretion in Polycystic Ovarian Disease

  2014cites this paper
• Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases

  2014cites this paper
• Gender differences in T cell regulation and responsesto sex hormones

  2014cites this paper
• The role and regulation of histone H2B monoubiquitination during tumorigenesis

  2014cites this paper
• Activin A Suppresses Osteoblast Mineralization Capacity by Altering Extracellular Matrix (ECM) Composition and Impairing Matrix Vesicle (MV) Production*

  2013cites this paper
• ONCOGENE DEPENDENT REGULATION OF MIGRATION AND PROLIFERATION IN HUMAN TUMOR CELLS

  2013cites this paper
• An In Vivo Model of Breast Cancer Prevention

  2013cites this paper
• A Study of the Genetics and Physical Properties of Dentine Defects

  2013cites this paper
• [Role of Activin A and Myostatin in cancer cachexia].

  2013cites this paper
• Activin receptor antagonists for cancer-related anemia and bone disease

  2013cites this paper
• Follistatin as potential therapeutic target in prostate cancer

  2013cites this paper
• Activin‐βc reduces reproductive tumour progression and abolishes cancer‐associated cachexia in inhibin‐deficient mice

  2013cites this paper
• The therapeutic potential of blocking the activin signalling pathway.

  2013cites this paper
• Diagnostic Role of Inhibin &agr;-Subunit and Inhibin/Activin &bgr;-Subunit in Adrenal Cortical and Medullary Tumors in Egyptian Patients

  2012cites this paper
• Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells

  2012cites this paper
• The bright and the dark sides of activin in wound healing and cancer

  2012cites this paper
• Pregnancy and Its Disorders

  2012cites this paper
• High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling.

  2012cites this paper
• Local Control of Steroid Hormone Biosynthesis

  2012influential citation
• Activins and activin antagonists in the prostate and prostate cancer.

  2012cites this paper
• Mammalian foetal ovarian development: consequences for health and disease.

  2012cites this paper
• Neutralisants de l'activine et leurs utilisations pour le traitement de maladies associées à une activation de la réponse de défense hôte

  2012cites this paper
• Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes

  2012cites this paper
• Increased serum activin‐A differentiates alcoholic from cirrhosis of other aetiologies

  2012cites this paper
• Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

  2012cites this paper
• Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer

  2012cites this paper
• Mutations in inhibin and activin genes associated with human disease.

  2012cites this paper
• Transcriptional silencing of the inhibin-α gene in human gastric carcinoma cells.

  2012cites this paper
• Conditional activin receptor type 1B (Acvr1b) knockout mice reveal hair loss abnormality.

  2011cites this paper
• inhibiting the acquisition of anti-inflammatory macrophage markers Running head : Activin A skews macrophage polarization

  2011cites this paper
• Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers.

  2011cites this paper
• Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response

  2011cites this paper
• Myostatin as a Potential Therapeutic Target for Obesity and Insulin Resistance

  2011cites this paper
• Inhibin-α subunit in normal and malignant human cervical tissue and cervical cancer cell lines.

  2011cites this paper
• Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?

  2011influential citation
• Antagonism of activin by activin chimeras.

  2011cites this paper
• Inhibin/activin betaE-subunit in uterine endometrioid adenocarcinoma and endometrial cancer cell lines: from immunohistochemistry to clinical testing?

  2011cites this paper
• The role of activins and their antagonists in human melanoma cell lines

  2011cites this paper
• The Local Control of the Pituitary by Activin Signaling and Modulation.

  2011cites this paper
• Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line

  2011influential citation
• The Role of Activin in Mammary Gland Development and Oncogenesis

  2011cites this paper
• Regulation and Function of GATA Transcription Factors in Adrenocortical Tumors and Granulosa Cells

  2011cites this paper
• Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.

  2011cites this paper
• Involvement of activin signaling in abnormalities of mouse vagina exposed neonatally to diethylstilbestrol

  2011cites this paper
• Inhibin beta B: a useful tumor marker in uterine endometrioid adenocarcinomas?

  2011cites this paper
• Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer

  2011cites this paper
• Expression und funktionelle Bedeutung von Aktivin A und Aktivin-Rezeptoren in der Hypophyse und in Hypophysentumorzellen

  2011cites this paper
• Serum follistatin in patients with prostate cancer metastatic to the bone

  2010cites this paper
• Genetic and gene expression analysis of nasopharyngeal carcinoma (NPC)

  2010cites this paper
• LIM homeodomain transcription factor Isl-1 enhances follicle stimulating hormone-beta and luteinizing hormone-beta gene expression and mediates the activation of leptin on gonadotropin synthesis.

  2010cites this paper
• Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues.

  2010cites this paper
• Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue

  2010cites this paper
• Inhibin A is down-regulated during chemotherapy in patients with breast cancer.

  2010cites this paper
• Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.

  2010cites this paper
• Immunolabeling of the Inhibin-&bgr;A and -&bgr;B Subunit in Normal and Malignant Human Cervical Tissue and Cervical Cancer Cell Lines

  2010cites this paper
• Overexpression of Activin A in Oral Squamous Cell Carcinoma: Association with Poor Prognosis and Tumor Progression

  2010cites this paper
• Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line

  2010cites this paper
• Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.

  2010cites this paper
• The Hypothalamic-Pituitary-Ovarian Axis

  2010cites this paper
• More than an accessory: implications of type III transforming growth factor‐β receptor loss in prostate cancer

  2010cites this paper
• Loss of Function of E-Cadherin in Embryonic Stem Cells and the Relevance to Models of Tumorigenesis

  2010cites this paper
• Immunohistochemical localization of inhibin and activin subunits, activin receptors and Smads in ovarian endometriosis.

  2009cites this paper